<unk> (oral) is an aminoglycoside that is FDA approved for the treatment of hepatic Coma and suppression of intestinal bacteria. There is a Black Box Warning for this drug as shown here.  Common adverse reactions include nausea, vomiting, diarrhea, nephrotoxicity, ototoxicity and neuromuscular blockage.
Neomycin 
Dactinomycin
Kanamycin
Amrubicin
Lincomycin Hydrochloride
Valrubicin
Apramycin
Tiazofurine